453 million patients were touched by Sandoz generic and biosimilar medicines in 2022 and while we’re proud of this, we know there is more we could do to continue to help pioneer access to medicines for people around the world.

How will we do this? We believe new insights, perspectives, and ground-breaking solutions can be found at the intersection of medical science and digital innovation. That a diverse, equitable, and inclusive environment inspires new ways of working.

We believe our potential can thrive and grow in an unbossed culture underpinned by integrity, curiosity, and flexibility. And we can reinvent what's possible when we collaborate with the courage to aggressively and ambitiously tackle the world’s toughest medical challenges. Because the greatest risk in life is the risk of never trying!

Imagine what you could do at Sandoz!

Hide full description